Literature DB >> 193666

Non-stedy-state studies of low-density-liproprotein turnover in familial hypercholesterolaemia.

G R Thompson, T Spinks, A Ranicar, N B Myant.   

Abstract

1. The non-steady-state turnover of low-density lipoprotein (LDL), labelled in its apoprotein moiety (apo-B) with 131I, was determined in four patients with familial hypercholesterolaemia, three of them homozygotes. 2. The fractional and absolute catabolic rates (FCR and ACR) of LDL-apo-B were determined by relating the excretion of radioactivity, measured in urine in vitro and by whole-body counter in vivo, to plasma radioactivity and to LDL specific radioactivity respectively. 3. The FCR remained relatively constant, even after marked reduction of LDL pool size by means of plasma exchange. This confirms the existence of an intrinsic defect in LDL catabolism in familial hypercholesterolaemia. 4. LDL-apo-B synthesis, determined by summing the ACR and the daily increment in plasma LDL, was much higher in the three homozygotes than in the one heterozygote, in whom the synthetic rate was normal. 5. These results illustrate the usefulness of combining plasma exchange and whole-body radioactivy counting as a means of examining the relationship between the turnover and pool size of a 131I-labelled protein, such as LDL.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193666     DOI: 10.1042/cs0520361

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  6 in total

1.  Plasma lipid and apoprotein levels following plasmapheresis in a subject homozygous for familial hypercholesterolemia.

Authors:  S I Barr; B A Kottke; A A Pineda; S J Mao
Journal:  Experientia       Date:  1981-02-15

2.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.

Authors:  D W Bilheimer; N J Stone; S M Grundy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

3.  Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.

Authors:  Y A Kesäniemi; W F Beltz; S M Grundy
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

Authors:  D R Illingworth; G J Sexton
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

Review 5.  The metabolic basis of familial hypercholesterolemia.

Authors:  N B Myant
Journal:  Klin Wochenschr       Date:  1983-04-15

6.  Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.

Authors:  G R Thompson; A K Soutar; F A Spengel; A Jadhav; S J Gavigan; N B Myant
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.